General description
Irinotecan is an antineoplastic topoisomerase I inhibitor used in the treatment of colorectal cancer.
INN
Irinotecan
Medicine type
Chemical agent
EML status history
First added in 2015
(TRS
994)
for
Malignant neoplasm metastasis in large intestine
Wikipedia
DrugBank
Recommendations
Section
Cytotoxic medicines
- Parenteral > General injections > IV: 40 mg per 2 mL in 2 mL vial; 100 mg per 5 mL in 5 mL vial; 500 mg per 25 mL in 25 mL vial
Indications